Hofseth BioCare ASA (FRA:HBQ)

Market Cap	49.08M -52.7%
Revenue (ttm)	21.66M -3.5%
Net Income	-11.40M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0916
Previous Close	0.0914
Day's Range	0.0916 - 0.0944
52-Week Range	0.0808 - 0.2570
Beta	n/a
RSI	48.84
Earnings Date	Feb 13, 2026

About Hofseth BioCare ASA

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2000
• Employees: 75
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: HBQ

Financial Performance

In 2025, Hofseth BioCare ASA's revenue was 256.34 million, a decrease of -3.46% compared to the previous year's 265.54 million. Losses were -134.88 million, 7.65% more than in 2024.

Financial numbers in NOK